Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Ruxolitinib treatment may cause eyelash growth.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Axitinib treatment turned a man's grey hair back to black.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Use topical corticosteroids for alopecia areata, consider systemic treatments like corticosteroids or JAK inhibitors for severe cases, and inform about cosmetic options.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.